IHE ETF Research - iShares DJ U.S. Pharmaceutical Index Fund

iShares DJ U.S. Pharmaceutical Index Fund (ihe)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 111

Threats + Weaknesses = 70

When strengths & opportunities substantially exceed threats & weaknesses an investment in the ihe ETF has great long term potential.

ETF Description Update

iShares DJ U.S. Pharmaceutical (IHE) Description: IHE is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. IHE exchange trading fund (ETF) tracks the U.S. Select Pharmaceuticals; this equity index measures the performance of the pharmaceuticals sector of the u.s. equity market. iShares DJ U.S. Pharmaceutical (IHE) falls under the Health & Biotech Equities category. IHE's dividend yield is roughly 1.47%, it has an expense ratio of 0.48%, and is in the equity ETF asset class. iShares DJ U.S. Pharmaceutical (IHE) focuses its investments in the U.S. region of the world. IHE does not use leverage and IHE's performance is meant to match its benchmark. The IHE ETF belongs to the Health & Biotech sector. An investor can find IHE's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features IHE's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on iShares ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain iShares DJ U.S. Pharmaceutical Index Fund (IHE)'s strategy.

Performance Analysis Update